Intragastric Balloon for Obesity Treatment: Safety, Tolerance, and Efficacy
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Background: Obesity is an increasing worldwide problem associated with a vast number of comorbidities. Decreasing body weight by only 5-10% has been shown to slow and even prevent the onset of obesity-related comorbidities. Between pharmacological therapy and bariatric surgery a great variety of endoscopic techniques are available, the most common being intragastric balloon (IGB). The purpose of this study was to assess the safety, tolerance, and kinetics of IGBs in weight loss. The kinetics of weight loss were evaluated in 2 different contexts and phases: after the IGB's removal and after follow-up that varied between 6 and 12 months. Successful weight loss was defined as ≥10% weight loss after 6-12 months. Methods: The study included 51 patients who had undergone Orbera® IGB placement between September 2014 and February 2016. Inclusion criteria were age between 18 and 65 years; body mass index (BMI) 28-35 with severe obesity-related disorders; or BMI 35-40. The IGB was removed 6 months later. All patients were followed for a minimum period of 6-12 months. Results: Of 51 patients, 16 were excluded (7 due to intolerance) and 35 patients entered the study, of which 83% were followed for more than 6-12 months. The average weight loss (WL) and % excess WL (%EWL) after 6 months of treatment were 11.94 kg and 42.16%, respectively. At 6-12 months, after removal of the IGB, the mean WL was 8.25 kg and %EWL was 30.27%. Nineteen patients attained a WL of ≥10% the baseline value at IGB removal and 12 maintained their weight below this threshold during the 6-12 following months. Conclusions: After temporary IGB implantation in overweight or obese individuals, a WL that was ≥10% of weight at baseline was achieved in 54.3% and sustained at 6-12 months in 41.4% of participants. IGBs are an attractive intermediate option between diet and exercise programs and bariatric surgery. In general, IGB placement is a safe and well-tolerated procedure.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Loveman, E., Frampton, G., Shepherd, J., Picot, J., Cooper, K., Bryant, J., Welch, K., & Clegg, A. (2011) · Health Technology Assessment · doi:10.3310/hta15020 · Cited by 296
Kumar, N. (2015) · World Journal of Gastrointestinal Endoscopy · doi:10.4253/wjge.v7.i9.847 · Cited by 90
Cited by
Benefits of weight loss of 10% or more in patients with overweight or obesity: A review
Tahrani, A. A., & Morton, J. (2022) · Obesity · doi:10.1002/oby.23371 · Cited by 125
Vantanasiri, K., Matar, R., Beran, A., & Jaruvongvanich, V. (2020) · Obesity Surgery · doi:10.1007/s11695-020-04522-3 · Cited by 49
“Orbera intragastric balloon is currently the most widely used [24, 25], which offered %TWL of 13.”
BackgroundEndoscopic bariatrics: current therapies and future directions
Reja, D., Zhang, C., & Sarkar, A. (2022) · Translational Gastroenterology and Hepatology · doi:10.21037/tgh.2020.03.09 · Cited by 24
“The Orbera is the most commonly used IGB in the world, with close to 300,000 devices already distributed (18).”
Background
Metadata
- Authors
- Ribeiro da Silva, J., Proença, L., Rodrigues, A., Pinho, R., Ponte, A., Rodrigues, J., Sousa, M., Almeida, R., & Carvalho, J.
- Venue
- GE - Portuguese Journal of Gastroenterology
- Publisher
- S. Karger AG
- Published
- 2017-12-21
- Volume
- 25
- Issue
- 5
- Pages
- 236-242
- ISSN
- 0872-8178 (ISSN-L)
- 2341-4545
- 2387-1954
- OpenAlex
- W2779765112
- Cited by
- 35
- References
- 2
- FWCI
- 3.28
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Intragastric Balloon for Obesity Treatment: Safety, Tolerance, and Efficacy. https://app.cochat.ai/papers/10.1159/000485428
- The paper
- Ribeiro da Silva, J., Proença, L., Rodrigues, A., Pinho, R., Ponte, A., Rodrigues, J., Sousa, M., Almeida, R., & Carvalho, J. (2018). Intragastric Balloon for Obesity Treatment: Safety, Tolerance, and Efficacy. GE - Portuguese Journal of Gastroenterology. https://doi.org/10.1159/000485428
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.